These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 11364123)

  • 21. [Cerebrospinal fluid viral load in HIV-1 positive hemophilic patients treated with HAART].
    Corti ME; Villafañe MF; Baré P; Alves Rosa F; Cermelj M; Candela M; Pérez Bianco R; Tezanos Pinto M
    Medicina (B Aires); 2001; 61(6):821-4. PubMed ID: 11808421
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of non-viral load surrogate markers in HIV-positive patient monitoring during antiviral treatment.
    Florence E; Dreezen C; Schrooten W; Van Esbroeck M; Kestens L; Fransen K; De Roo A; Colebunders R
    Int J STD AIDS; 2004 Aug; 15(8):538-42. PubMed ID: 15307965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced mortality and CD4 cell loss among carriers of the interleukin-10 -1082G allele in a Zimbabwean cohort of HIV-1-infected adults.
    Erikstrup C; Kallestrup P; Zinyama-Gutsire RB; Gomo E; Butterworth AE; Pedersen BK; Ostrowski SR; Gerstoft J; Ullum H
    AIDS; 2007 Nov; 21(17):2283-91. PubMed ID: 18090276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The prognostic value of virology and immunology markers in Chinese HIV-1 infected people].
    Lin X; Xu L; Shao Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1999 Mar; 13(1):41-4. PubMed ID: 12759951
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum neopterin, an immune activation marker, independently predicts disease progression in advanced HIV-1 infection.
    Mildvan D; Spritzler J; Grossberg SE; Fahey JL; Johnston DM; Schock BR; Kagan J
    Clin Infect Dis; 2005 Mar; 40(6):853-8. PubMed ID: 15736019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New study on viral load.
    Posit Aware; 1996; 7(1):5. PubMed ID: 11363123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A decade of research on the natural history of HIV infection: Part 1. Markers.
    Strathdee SA; O'Shaughnessy MV; Montaner JS; Schechter MT
    Clin Invest Med; 1996 Apr; 19(2):111-20. PubMed ID: 8697670
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo detection and quantitation of HIV in blood and tissues.
    Cavert W
    AIDS; 1998; 12 Suppl A():S27-34. PubMed ID: 9632981
    [No Abstract]   [Full Text] [Related]  

  • 29. Advances in HIV markers.
    Elliott EB
    Can Fam Physician; 1996 Nov; 42():2301-2. PubMed ID: 8939326
    [No Abstract]   [Full Text] [Related]  

  • 30. Statistical issues for HIV surrogate endpoints: point/counterpoint. An NIAID workshop.
    Albert JM; Ioannidis JP; Reichelderfer P; Conway B; Coombs RW; Crane L; Demasi R; Dixon DO; Flandre P; Hughes MD; Kalish LA; Larntz K; Lin D; Marschner IC; Muñoz A; Murray J; Neaton J; Pettinelli C; Rida W; Taylor JM; Welles SL
    Stat Med; 1998 Nov; 17(21):2435-62. PubMed ID: 9819838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Variations in viral load still under investigation.
    Smart T
    GMHC Treat Issues; 1995 Sep; 9(9):12-4. PubMed ID: 11362905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sulfasalazine: arthritis drug increases CD4 count?
    Smith D
    AIDS Treat News; 1995 Mar; (no 218):6-7. PubMed ID: 11362329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV-producing T cells in cerebrospinal fluid.
    Neuenburg JK; Sinclair E; Nilsson A; Kreis C; Bacchetti P; Price RW; Grant RM
    J Acquir Immune Defic Syndr; 2004 Oct; 37(2):1237-44. PubMed ID: 15385730
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Virologic parameters as surrogate markers for clinical outcome in HIV-1 disease: verification, variation, and validation.
    Reichelderfer PS; Coombs RW
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 2():S19-24. PubMed ID: 7552509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebrospinal fluid HIV viral load in different phases of HIV-associated brain disease.
    von Giesen HJ; Adams O; Köller H; Arendt G
    J Neurol; 2005 Jul; 252(7):801-7. PubMed ID: 15750706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cofactors, coreceptors, and new retroviruses. An interview with Robin A Weiss, PhD. Interview by Mark Mascolini.
    Weiss RA
    J Int Assoc Physicians AIDS Care; 1995 Feb; 1(1):6-10. PubMed ID: 11362234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surrogate markers of HIV infection.
    Can Commun Dis Rep; 1995 Dec; 21(24):215-6. PubMed ID: 8605499
    [No Abstract]   [Full Text] [Related]  

  • 38. Surrogate markers for assessing treatment response in HIV disease.
    Rathbun RC
    Ann Pharmacother; 1993 Apr; 27(4):450-5. PubMed ID: 8097416
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surrogate markers in HIV disease.
    Peto T
    J Antimicrob Chemother; 1996 May; 37 Suppl B():161-70. PubMed ID: 8818838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurosyphilis During Acute HIV Infection: A CNS Immunologic and Virologic Characterization.
    Chan P; Dumrongpisutikul N; Subra C; Colby DJ; Kroon E; Fletcher J; Sacdalan C; Phanuphak N; Valcour V; Ananworanich J; Trautmann L; Spudich S
    J Acquir Immune Defic Syndr; 2019 Oct; 82(2):e34-e37. PubMed ID: 31180994
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.